8 drug(s) with this reaction
12,953 total reports
Joint Swelling has been reported as an adverse reaction across 8 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 12,953 adverse event reports mention joint swelling in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with joint swelling, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have joint swelling listed in their FDA adverse event reports, sorted by report count:
In addition to joint swelling, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
8 drug(s) manufactured by Haleon Us Holdings Llc have joint swelling listed in their FDA adverse event reports: DICLOFENAC SODIUM, CALCIUM CARBONATE, FLUTICASONE PROPIONATE, IBUPROFEN SODIUM, IBUPROFEN TABLETS, COATED, and others.
There are a combined 12,953 reports of joint swelling across 8 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.